Congress doesn't help Amgen

WASHINGTON - The omnibus spending bill signed by President Clinton last week was packed with provisions favoring special interests, but despite extensive lobbying efforts, Amgen Inc. and Schering-Plough Corp. were not among the beneficiaries.

AMGN had been trying to amend the Hatch-Waxman Act in an effort to counter

Read the full 477 word article

How to gain access

Continue reading with a
two-week free trial.